CTKB – cytek biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results [Yahoo! Finance]
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results
Cytek Biosciences (NASDAQ:CTKB) had its price target raised by analysts at TD Cowen from $4.00 to $5.00. They now have a "buy" rating on the stock.
Cytek Biosciences (NASDAQ:CTKB) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.
Form 8-K Cytek Biosciences, Inc. For: Jan 12
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Yan Ming
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Busque Philippe
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Barnett Valerie
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: McCombe William D.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.